Managing Director, Equity Research-Special Situations and Consumer Products, GMP Securities
Martin Landry has 18 years of experience in accounting and capital markets. Landry started his professional career in 2001 with Ernst & Young in auditing before transitioning into capital markets in 2005.
As a Managing Director with GMP Securities he provides equity research coverage on Canadian medical marijuana producers as well as consumer product companies. Landry has been covering the Canadian medical cannabis industry since its inception in 2013.
In 2017, Martin ranked first amongst Canadian equity analysts for Small Cap/Special Situations research in Brendan Wood International. He was also designated top stock picker by Thomson Reuters in the Health Care sector for 2017. Landry also holds a Chartered Professional Accountant designation.